Vaccine-related influenza virus B infection in a child with an undiagnosed B-cell acute lymphoblastic leukemia.

immunocompromised patient influenza virus leukemia live vaccine

Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
19 Jul 2024
Historique:
received: 20 03 2024
revised: 15 07 2024
accepted: 16 07 2024
medline: 22 7 2024
pubmed: 22 7 2024
entrez: 21 7 2024
Statut: aheadofprint

Résumé

We report a case of Influenza type B (lineage Yamagata) infection in a child who received the live attenuated influenza virus vaccine before being diagnosed with B-cell acute lymphoblastic leukemia. The patient developed a mild disease that persisted for 18 days and resolved without antiviral treatment. The prolonged infection of an attenuated virus in an immunocompromised host might pose a risk of reversion or evolution to a more pathogenic strain. Prompt prevention, identification, and monitoring of similar cases are desirable to avoid the development of severe illness, which could complicate patient management.

Identifiants

pubmed: 39033799
pii: S1201-9712(24)00255-8
doi: 10.1016/j.ijid.2024.107184
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107184

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Giuseppe Di Pietra (GD)

Department of Molecular Medicine, University of Padua, Via Gabelli, 63, Padua, 35121, Italy.

Sarah Di Sopra (SD)

Department of Molecular Medicine, University of Padua, Via Gabelli, 63, Padua, 35121, Italy.

Valeria Conciatori (V)

Department of Molecular Medicine, University of Padua, Via Gabelli, 63, Padua, 35121, Italy.

Enrico Lavezzo (E)

Department of Molecular Medicine, University of Padua, Via Gabelli, 63, Padua, 35121, Italy.

Elisa Franchin (E)

Department of Molecular Medicine, University of Padua, Via Gabelli, 63, Padua, 35121, Italy; Microbiology and Virology Diagnostic Unit, Padua University Hospital, Via Giustiniani 2, Padua, 35128, Italy.

Maria Grazia Petris (MG)

Pediatric Onco-Hematology Division Unit, Padua University Hospital, Via Giustiniani 2, Padua, 35128, Italy.

Alessandra Biffi (A)

Pediatric Onco-Hematology Division Unit, Padua University Hospital, Via Giustiniani 2, Padua, 35128, Italy.

Ignazio Castagliuolo (I)

Department of Molecular Medicine, University of Padua, Via Gabelli, 63, Padua, 35121, Italy; Microbiology and Virology Diagnostic Unit, Padua University Hospital, Via Giustiniani 2, Padua, 35128, Italy.

Cristiano Salata (C)

Department of Molecular Medicine, University of Padua, Via Gabelli, 63, Padua, 35121, Italy.

Claudia Del Vecchio (CD)

Department of Molecular Medicine, University of Padua, Via Gabelli, 63, Padua, 35121, Italy; Microbiology and Virology Diagnostic Unit, Padua University Hospital, Via Giustiniani 2, Padua, 35128, Italy. Electronic address: claudia.delvecchio@unipd.it.

Classifications MeSH